Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure

NCT: NCT06511414 · ACTIVE_NOT_RECRUITING

NCT IDNCT06511414
StatusACTIVE_NOT_RECRUITING
Start Date2024-01-03
Completion2026-12

Brief Summary

Diverting ileostomy is frequently utilized to protect high-risk anastomoses, though it is not shown to reduce the leak rate it may reduce the severe consequences of an anastomotic leak. Ileostomy will be reversed with restoration of continuity in majority of patients. Stoma site incisional hernias after ileostomy closure are complex hernias that can be associated with abdominal pain, discomfort, and a diminished quality of life. Duramesh™ non-absorbable polypropylene suture is a hollow core, microporous, cylindrical suture made off in polypropylene filaments that are loosely braided and bonded to each other with heat and pressure. The Aim of this study is to evaluate Duramesh™ suture vs standard closure on rates of hernia formation after ileostomy closure.

Frequently Asked Questions

What is Effect of Duramesh™ on Hernia Formation After Ileostomy Closure?

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure is a clinical trial registered under NCT06511414. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06511414?

The current status of NCT06511414 (Effect of Duramesh™ on Hernia Formation After Ileostomy Closure) is: ACTIVE_NOT_RECRUITING.

When did Effect of Duramesh™ on Hernia Formation After Ileostomy Closure start?

Effect of Duramesh™ on Hernia Formation After Ileostomy Closure started on 2024-01-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.